From powerhouse to precision target: Global experts unite in Berlin to advance mitochondrial medicine
Updated Targeting Mitochondria 2025 program showcases breakthroughs in transplantation, organelle transfer, and novel therapies. Cutting-edge research in mitochondrial transplantation, intercellular organelle transfer, and novel therapeutics to take cente
image: We are excited to invite you to the 16th World Congress on Targeting Mitochondria, happening from October 22–24, 2025, in Berlin.
Credit: World Mitochondria Society
Mitochondria are no longer viewed solely as the cell’s “powerhouses.” They are now recognized as central regulators of human health, disease, and aging, influencing everything from energy production and metabolism to immune function and cell fate. Advances in mitochondrial research are driving new frontiers in precision medicine, offering novel approaches for diagnosing, preventing, and treating a broad range of conditions, including neurodegenerative disorders, metabolic syndromes, cardiovascular disease, cancer, and age-related decline.
The World Mitochondria Society today announced the updated scientific program for the 16th World Congress on Targeting Mitochondria, taking place October 22–24, 2025 in Berlin, Germany. This year’s agenda showcases pioneering research and disruptive technologies that aim to translate basic mitochondrial science into transformative medical applications.
The meeting will open with two in-depth workshops:
- Mitochondria Function Evaluation – advanced methods, biomarkers, and practical case studies, led by Naïg Gueguen (Mitovasc Institute, France).
- Mitochondria Transplantation – from theory to clinical applications, presented by Andrés Caicedo (Universidad San Francisco de Quito, Ecuador).
Keynote speakers include:
- Nick Lane (University College London, UK): Mitochondria and the Meaning of Life
- Adam Szewczyk (Nencki Institute, Poland): Targeting Mitochondrial Channels: Updates and Strategies
The updated agenda will highlight advances in:
- Intercellular mitochondrial transfer in cancer progression and immune modulation
- Mitochondrial-derived vesicles as mediators of cellular communication
- Organoid and cybrid models for mitochondrial disease research and drug discovery
- Corrective strategies for mitochondrial mutations and metabolic reprogramming
- Clinical translation of mitochondrial-based therapies and ongoing trials
“Mitochondria are emerging as central regulators of health, disease, and aging” said Volkmar Weissig, President of the World Mitochondria Society. “The 2025 program brings together pioneering research that will help translate this knowledge into precision diagnostics, targeted therapies, and preventive strategies”.
The congress will also feature expanded short oral presentation sessions, offering early-career scientists and industry innovators an opportunity to present their latest work. Networking events, including the “Meet the Speakers” dinner, will encourage cross-disciplinary collaborations.
Event details:
π October 22–24, 2025
π Berlin, Germany
π Full program and registration: www.wms-site.com
βΈ»
About the World Mitochondria Society
The World Mitochondria Society (WMS) is dedicated to advancing research and clinical applications in mitochondrial science. Through its annual congress and collaborative initiatives, WMS provides a global platform for exchanging knowledge, fostering innovation, and accelerating the development of mitochondria-based diagnostics and therapies.